Logo image of NVJP.DE

UMICORE (NVJP.DE) Stock Fundamental Analysis

FRA:NVJP - Deutsche Boerse Ag - BE0974320526 - Common Stock - Currency: EUR

14.74  +0.52 (+3.66%)

Fundamental Rating

3

Overall NVJP gets a fundamental rating of 3 out of 10. We evaluated NVJP against 67 industry peers in the Chemicals industry. NVJP has a bad profitability rating. Also its financial health evaluation is rather negative. NVJP is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

NVJP had positive earnings in the past year.
NVJP had a positive operating cash flow in the past year.
Of the past 5 years NVJP 4 years were profitable.
Each year in the past 5 years NVJP had a positive operating cash flow.
NVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFNVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

NVJP has a Return On Assets of -15.72%. This is amonst the worse of the industry: NVJP underperforms 80.60% of its industry peers.
NVJP's Return On Equity of -76.36% is on the low side compared to the rest of the industry. NVJP is outperformed by 85.07% of its industry peers.
Industry RankSector Rank
ROA -15.72%
ROE -76.36%
ROIC N/A
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
NVJP.DE Yearly ROA, ROE, ROICNVJP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

The Gross Margin of NVJP (8.17%) is worse than 82.09% of its industry peers.
NVJP's Gross Margin has improved in the last couple of years.
NVJP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
NVJP.DE Yearly Profit, Operating, Gross MarginsNVJP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

2

2. Health

2.1 Basic Checks

NVJP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NVJP has about the same amount of shares outstanding.
NVJP has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, NVJP has a worse debt to assets ratio.
NVJP.DE Yearly Shares OutstandingNVJP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NVJP.DE Yearly Total Debt VS Total AssetsNVJP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 1.74, we must say that NVJP is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.74, NVJP is not doing good in the industry: 67.16% of the companies in the same industry are doing better.
NVJP has a debt to FCF ratio of 12.00. This is a negative value and a sign of low solvency as NVJP would need 12.00 years to pay back of all of its debts.
The Debt to FCF ratio of NVJP (12.00) is better than 61.19% of its industry peers.
A Debt/Equity ratio of 1.49 is on the high side and indicates that NVJP has dependencies on debt financing.
With a Debt to Equity ratio value of 1.49, NVJP is not doing good in the industry: 83.58% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF 12
Altman-Z 1.74
ROIC/WACCN/A
WACC5.91%
NVJP.DE Yearly LT Debt VS Equity VS FCFNVJP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

NVJP has a Current Ratio of 1.28. This is a normal value and indicates that NVJP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.28, NVJP is doing worse than 74.63% of the companies in the same industry.
A Quick Ratio of 0.77 indicates that NVJP may have some problems paying its short term obligations.
NVJP's Quick ratio of 0.77 is on the low side compared to the rest of the industry. NVJP is outperformed by 79.10% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.77
NVJP.DE Yearly Current Assets VS Current LiabilitesNVJP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

NVJP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -43.01%.
NVJP shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.85% yearly.
The Revenue for NVJP has decreased by -18.68% in the past year. This is quite bad
NVJP shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.21% yearly.
EPS 1Y (TTM)-43.01%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%-35.96%
Revenue 1Y (TTM)-18.68%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-8.4%

3.2 Future

Based on estimates for the next years, NVJP will show a small growth in Earnings Per Share. The EPS will grow by 7.13% on average per year.
The Revenue is expected to grow by 1.83% on average over the next years.
EPS Next Y-3.54%
EPS Next 2Y0.94%
EPS Next 3Y3.83%
EPS Next 5Y7.13%
Revenue Next Year-5.32%
Revenue Next 2Y-0.3%
Revenue Next 3Y-0.2%
Revenue Next 5Y1.83%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NVJP.DE Yearly Revenue VS EstimatesNVJP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
NVJP.DE Yearly EPS VS EstimatesNVJP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.91 indicates a correct valuation of NVJP.
Based on the Price/Earnings ratio, NVJP is valued cheaply inside the industry as 83.58% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.41. NVJP is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 14.42, which indicates a correct valuation of NVJP.
NVJP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NVJP is cheaper than 64.18% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.19. NVJP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.91
Fwd PE 14.42
NVJP.DE Price Earnings VS Forward Price EarningsNVJP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

NVJP's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NVJP is cheaper than 83.58% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.68
EV/EBITDA N/A
NVJP.DE Per share dataNVJP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.94%
EPS Next 3Y3.83%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.46%, NVJP has a reasonable but not impressive dividend return.
NVJP's Dividend Yield is a higher than the industry average which is at 2.99.
NVJP's Dividend Yield is comparable with the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 2.46%

5.2 History

The dividend of NVJP has a limited annual growth rate of 0.67%.
Dividend Growth(5Y)0.67%
Div Incr Years0
Div Non Decr Years4
NVJP.DE Yearly Dividends per shareNVJP.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

The earnings of NVJP are negative and hence is the payout ratio. NVJP will probably not be able to sustain this dividend level.
NVJP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-13%
EPS Next 2Y0.94%
EPS Next 3Y3.83%
NVJP.DE Yearly Income VS Free CF VS DividendNVJP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

UMICORE

FRA:NVJP (7/11/2025, 7:00:00 PM)

14.74

+0.52 (+3.66%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-14 2025-02-14/bmo
Earnings (Next)08-01 2025-08-01
Inst Owners38.34%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.63B
Analysts65.71
Price Target11.96 (-18.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.46%
Yearly Dividend0.8
Dividend Growth(5Y)0.67%
DP-13%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.63%
PT rev (3m)0.65%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-26.45%
Valuation
Industry RankSector Rank
PE 13.91
Fwd PE 14.42
P/S 0.24
P/FCF 12.68
P/OCF 4.18
P/B 1.87
P/tB 2.34
EV/EBITDA N/A
EPS(TTM)1.06
EY7.19%
EPS(NY)1.02
Fwd EY6.94%
FCF(TTM)1.16
FCFY7.89%
OCF(TTM)3.53
OCFY23.92%
SpS60.28
BVpS7.87
TBVpS6.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.72%
ROE -76.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.17%
FCFM 1.93%
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
F-Score2
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF 12
Debt/EBITDA N/A
Cap/Depr 204.16%
Cap/Sales 3.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 0.77
Altman-Z 1.74
F-Score2
WACC5.91%
ROIC/WACCN/A
Cap/Depr(3y)224.12%
Cap/Depr(5y)196.78%
Cap/Sales(3y)3.57%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.01%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%-35.96%
EPS Next Y-3.54%
EPS Next 2Y0.94%
EPS Next 3Y3.83%
EPS Next 5Y7.13%
Revenue 1Y (TTM)-18.68%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-8.4%
Revenue Next Year-5.32%
Revenue Next 2Y-0.3%
Revenue Next 3Y-0.2%
Revenue Next 5Y1.83%
EBIT growth 1Y-313.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.35%
EBIT Next 3Y19.67%
EBIT Next 5Y15.5%
FCF growth 1Y81.43%
FCF growth 3Y-30.19%
FCF growth 5YN/A
OCF growth 1Y-16.68%
OCF growth 3Y-11.62%
OCF growth 5Y12.64%